Eisner Mark — SEC Form 4 filings
SEC reporting owner CIK 1834161. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-26.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-07-16 to 2026-06-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 15,976 shares, $106,314 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 6,796 shares @ $5.47 ($37,162) in Vir Biotechnology, Inc., filed 2025-07-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | EVP and Chief Medical Officer | 5 | — | 5 legs · 15,976 sh · $106,314 | 6 |
| Zura Bio Ltd (ZURA) | Director | 2 | — | — | 2 |
| Jade Biosciences, Inc. (JBIO) | Director | 1 | — | — | 1 |
Form 4 filings — Eisner Mark
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-26 | 4 | Jade Biosciences, Inc. (JBIO) | Grant/award (A): 47,675 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 51,000 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 1,616 @ $9.53 · Sale (S): 1,889 @ $9.82 | EDGAR |
| 2026-02-24 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 55,000 @ $0 · Sale (S): 2,089 @ $7.45 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 37,812 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 6,796 @ $5.47 · Sale (S): 3,586 @ $5.47 | EDGAR |
| 2025-02-25 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 40,000 @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2024-07-16 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 75,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1834161 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →